Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Moxifloxacin in Liver Resection Patients
NCT01302951Phase 4Completed
- Sponsor
- Saarland University Medical Center
- Start
- Jul 2008
- Primary completion
- Jul 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of moxifloxacin in bacterial infection (2 arms), sponsored by Saarland University Medical Center. Primary endpoint: Concentration of moxifloxacin in liver tissue at 1.5 hours. Started Jul 2008; status: completed.
02
Drugs
moxifloxacin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT01302951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01302951.